Navigation Links
The Gift of Life Flows Through Your Veins!
Date:7/23/2009

Diverse Donors Make the Difference

NEW YORK, July 23 /PRNewswire-USNewswire/ -- National Minority Donor Awareness Day is August 1, and New York Blood Center (NYBC) and its regions in Manhattan, Long Island, Hudson Valley, Brooklyn/Staten Island, and New Jersey call on the community to help us meet the great need for blood from diverse donors.

Historically, National Minority Donor Awareness Day emphasized minority organ and tissue donation, but blood donation remains the most widely used gift of life. Organ and tissue transplant procedures cannot take place without adequate blood supplies, and many patients have unique blood needs that can only be met by blood donors of the same ethnic or racial background.

Every two seconds, someone needs blood. Your community blood supply is a lifeline for you, your family, neighbors, and friends. NYBC serves one of the most diverse areas in the nation making it imperative that we not only maintain an ample blood supply, but also collect blood that closely mirrors the diversity of the communities we serve. A shortage of diverse blood donors can seriously jeopardize patient care.

Currently, NYBC donors are 71% White, 8.4% Hispanic/Latino, 6.8% Black/African American, and 4.6% Asian/Pacific Islander. Unfortunately, this does not mirror the diversity of our patient population.

The goal of New York Blood Center's PreciseMatch(R) Program is to ensure diverse communities have access to the most precisely matched blood products whenever patients might need them. Some chronically transfused patients, such as those with sickle cell disease, thalassemia, cancer or leukemia, pregnant women and newborn babies, can build up antibodies following frequent transfusions and may "reject" a transfusion or have a bad transfusi
'/>"/>

SOURCE New York Blood Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Greenway Medical Technologies PrimePatient Solution Transforms Physician/Patient Relationship Through Enhanced Communication Channels and Improved Workflows
2. uKarma Reports Progress With International Distribution Agreement for Its Xflowsion DVD Series
3. uKarma to Open First Xflowsion Fitness Studio With Celebrity Trainer Eric Paskel
4. uKarma Corporation Commences International Distribution Agreement With Northern Response for its Xflowsion DVD Series
5. George Institute receives Gates Foundation grant to survey funding flows
6. EAP Strengthens Service Offerings Through Deal With Broadspire
7. HealthFitness Helps Herbalife Engage Employees in Wellness Promotion Program Through Strategic Use of Incentives
8. Child Care Centers Throughout Mexico Being Crucified Unjustly, Says Interchildren, Inc.
9. Ready? AIM! Target Success! AIM Expands Global Reach Through Innovative Corporate Portal ... from Web to Enterprise 2.0
10. Los Angeles Cosmetic Dentist Sam Muslins Breakthrough Procedure: Face Lift Dentistry
11. National Council on Skin Cancer Prevention Encourages Americans to Obtain Vitamin D Through Diet and Supplements
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin An Investigational Treatment for Type 2 Diabetes 4914 1Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin An Investigational Treatment for Type 2 Diabetes 4914 2Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin An Investigational Treatment for Type 2 Diabetes 4914 3IBM Scientists First to Image the Anatomy of a Molecule 4913 1IBM Scientists First to Image the Anatomy of a Molecule 4913 2IBM Scientists First to Image the Anatomy of a Molecule 4913 3IBM Scientists First to Image the Anatomy of a Molecule 4913 4IBM Scientists First to Image the Anatomy of a Molecule 4913 5Four Studies Published in The Lancet Show roflumilast 28Daxas 28R 29 29 a New Oral Approach to COPD Improves Lung Function and Reduces Exacerbation 4911 1Four Studies Published in The Lancet Show roflumilast 28Daxas 28R 29 29 a New Oral Approach to COPD Improves Lung Function and Reduces Exacerbation 4911 2Four Studies Published in The Lancet Show roflumilast 28Daxas 28R 29 29 a New Oral Approach to COPD Improves Lung Function and Reduces Exacerbation 4911 3Four Studies Published in The Lancet Show roflumilast 28Daxas 28R 29 29 a New Oral Approach to COPD Improves Lung Function and Reduces Exacerbation 4911 4Four Studies Published in The Lancet Show roflumilast 28Daxas 28R 29 29 a New Oral Approach to COPD Improves Lung Function and Reduces Exacerbation 4911 5Four Studies Published in The Lancet Show roflumilast 28Daxas 28R 29 29 a New Oral Approach to COPD Improves Lung Function and Reduces Exacerbation 4911 6Four Studies Published in The Lancet Show roflumilast 28Daxas 28R 29 29 a New Oral Approach to COPD Improves Lung Function and Reduces Exacerbation 4911 7Four Studies Published in The Lancet Show roflumilast 28Daxas 28R 29 29 a New Oral Approach to COPD Improves Lung Function and Reduces Exacerbation 4911 8Four Studies Published in The Lancet Show roflumilast 28Daxas 28R 29 29 a New Oral Approach to COPD Improves Lung Function and Reduces Exacerbation 4911 9